Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins


Creative Commons License

Sahin E. , MADENDAĞ Y. , SAHIN M. E. , MADENDAG I. C. , AÇMAZ G. , Karakukcu C. , et al.

CANCER CONTROL, cilt.25, 2018 (SCI İndekslerine Giren Dergi)

Özet

Purpose: To evaluate cervical mucus secretory leukocyte protease inhibitor (SLPI) concentrations in patients with high-risk human papillomavirus (hrHPV) 16 or 18 positive and low-grade squamous intraepithelial lesions (LGSIL) or high-grade squamous intraepithelial lesions (HGSIL).